Document Detail

Effects of dimethindene maleate nasal spray on the quality of life in seasonal allergic rhinitis.
MedLine Citation:
PMID:  14579656     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To determine if the H1-receptor antagonist dimethindene maleate (DMM), topically applied, is able to improve the quality of life (QoL) in patients with seasonal allergic rhinitis better than placebo. METHODS: The study was a multi-centre, randomised, placebo-controlled, double-blinded phase III trial including 157 patients. Two parallel groups received either DMM nasal spray or placebo for 2 weeks. Patients answered 5 QoL questionnaires (Rhinoconjunctivitis QoL Questionnaire (LQ-AR), Munich Life Dimension List (MLDL), Profile of Mood States (POMS), 2 Visual Analogue Scales (VAS-QoL, VAS-GES)) on days 1, 4, 8, and 15. RESULTS: QoL improved significantly in all scales and groups. Statistically significant differences between groups were achieved in the sub-scales LQ-AR Eye Symptoms and Daily Activities, MLDL Total, POMS Depression and Energy, VAS-QoL and VAS-General Health. All differences favoured the DMM group and were present initially but disappeared in visit 4, except MLDL Total and POMS Energy. Almost all other scores had a better tendency of DMM. CONCLUSION: A significant improvement of QoL was found in both groups. Only weak differences between groups (in favour of DMM) were found. There are several reasons explaining this outcome, mainly the rainy weather during the study period (mean weather index 10-20% less sunny than in previous seasons).
C H Kirchhoff; B Kremer; S Haaf-von Below; H J Kyrein; R Mösges
Related Documents :
16158036 - Chronic venous disease: health status of a population and care impact on this health st...
12588616 - Quality of life of elderly japanese patients with glaucoma.
16614886 - Quality of life after hyperthermic isolated limb perfusion for locally advanced extremi...
19885296 - German-translated norfolk quality of life (qol-dn) identifies the same factors as the e...
24313916 - Efficacy and safety of certolizumab pegol plus methotrexate in japanese rheumatoid arth...
16088146 - Effect of implementation of a dyspepsia and helicobacter pylori eradication guideline i...
Publication Detail:
Type:  Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial    
Journal Detail:
Title:  Rhinology     Volume:  41     ISSN:  0300-0729     ISO Abbreviation:  Rhinology     Publication Date:  2003 Sep 
Date Detail:
Created Date:  2003-10-28     Completed Date:  2003-12-23     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  0347242     Medline TA:  Rhinology     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  159-66     Citation Subset:  IM    
Division of Plastic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Intranasal
Dimethindene / administration & dosage*
Double-Blind Method
Histamine H1 Antagonists / administration & dosage*
Middle Aged
Prospective Studies
Quality of Life*
Rhinitis, Allergic, Seasonal / drug therapy*
Treatment Outcome
Reg. No./Substance:
0/Histamine H1 Antagonists; 5636-83-9/Dimethindene

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pressures generated during nose blowing in patients with nasal complaints and normal test subjects.
Next Document:  Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with...